{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T07:09:13Z","timestamp":1763968153460},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ygyno.2015.05.023","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T08:42:24Z","timestamp":1432716144000},"page":"272-277","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant\/refractory ovarian, fallopian tube and primary peritoneal carcinoma"],"prefix":"10.1016","volume":"138","clinical-trial-number":[{"clinical-trial-number":"nct00617773","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Oren","family":"Smaletz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria D.P.E.","family":"Diz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio C.","family":"do Carmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Sabbaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldo F.","family":"Cunha-Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio J.","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando C.","family":"Maluf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos H.","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronaldo L.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana G.","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Madrigal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto J.","family":"Wainstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda P.","family":"Yeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ven\u00e2ncio A.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Moro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Blasbalg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric W.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2015.05.023_bb0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.ygyno.2015.05.023_bb0010","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2165\/11591720-000000000-00000","article-title":"Management strategies for recurrent platinum-resistant ovarian cancer","volume":"71","author":"Naumann","year":"2011","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.ygyno.2015.05.023_bb0015","first-page":"1553","article-title":"Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines","volume":"46","author":"Sakamoto","year":"1986","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ygyno.2015.05.023_bb0020","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/(SICI)1097-0215(19960208)65:4<406::AID-IJC2>3.0.CO;2-0","article-title":"Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer","volume":"65","author":"Yin","year":"1996","journal-title":"Int. J. Cancer"},{"issue":"26","key":"10.1016\/j.ygyno.2015.05.023_bb0025","doi-asserted-by":"crossref","first-page":"12957","DOI":"10.1073\/pnas.91.26.12957","article-title":"Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants","volume":"91","author":"Kitamura","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.ygyno.2015.05.023_bb0030","first-page":"3254","article-title":"Construction, production, and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors","volume":"60","author":"Scott","year":"2000","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.ygyno.2015.05.023_bb0035","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1158\/1078-0432.CCR-07-0284","article-title":"A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen","volume":"13","author":"Scott","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.ygyno.2015.05.023_bb0040","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/JTO.0b013e3181560dcc","article-title":"Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels","volume":"2","author":"Krug","year":"2007","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2015.05.023_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1634\/theoncologist.5-1-26","article-title":"Second-line treatment of ovarian cancer","volume":"5","author":"Markman","year":"2000","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.ygyno.2015.05.023_bb0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2015.05.023_bb0055","series-title":"Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0","year":"2006"},{"issue":"18","key":"10.1016\/j.ygyno.2015.05.023_bb0060","first-page":"6851","article-title":"Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33","volume":"61","author":"Ritter","year":"2001","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ygyno.2015.05.023_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/153685903322328947","article-title":"Generation of anti-idiotype antibodies for application in clinical immunotherapy laboratory analyses","volume":"22","author":"Liu","year":"2003","journal-title":"Hybrid. Hybridomics"},{"issue":"6","key":"10.1016\/j.ygyno.2015.05.023_bb0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/jnci\/djh081","article-title":"Re: new guidelines to evaluate the response to treatment in solid tumors (ovarian cancer)","volume":"96","author":"Rustin","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.ygyno.2015.05.023_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control. Clin. Trials"},{"issue":"14","key":"10.1016\/j.ygyno.2015.05.023_bb0080","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1200\/JCO.2001.19.14.3312","article-title":"Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan","volume":"19","author":"Gordon","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.05.023_bb0085","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1200\/JCO.2013.51.4489","article-title":"Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial","volume":"32","author":"Pujade-Lauraine","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2015.05.023_bb0090","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1200\/JCO.1997.15.4.1309","article-title":"High-dose chemotherapy with autologous transplantation for persistent\/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients","volume":"15","author":"Stiff","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2015.05.023_bb0095","first-page":"4517","article-title":"Clinical outcome of patients with advanced ovarian cancer after resection of liver metastases","volume":"32","author":"Neumann","year":"2012","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.ygyno.2015.05.023_bb0100","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/1097-0142(19871001)60:7<1561::AID-CNCR2820600725>3.0.CO;2-V","article-title":"Distant metastases in epithelial ovarian carcinoma","volume":"60","author":"Dauplat","year":"1987","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.ygyno.2015.05.023_bb0105","first-page":"840","article-title":"New agents and new formulations for the treatment of ovarian cancer","volume":"3","author":"Sabbatini","year":"2005","journal-title":"Clin. Adv. Hematol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815300056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815300056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T10:04:50Z","timestamp":1668593090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815300056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0090825815300056"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.05.023","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant\/refractory ovarian, fallopian tube and primary peritoneal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}